973
Views
3
CrossRef citations to date
0
Altmetric
Special Section: A Collection of Articles on Opportunities and Challenges in Utilizing Real-World Data for Clinical Trials and Medical Product Development

Good Data Science Practice: Moving Toward a Code of Practice for Drug Development

ORCID Icon, , , ORCID Icon, &
Pages 74-85 | Received 16 Jun 2021, Accepted 18 Mar 2022, Published online: 16 May 2022

References

  • Akacha, M., Bretz, F., and Ruberg, S. (2017), “Estimands in Clinical Trials – Broadening the Perspective,” Statistics in Medicine, 36, 5–19. DOI: 10.1002/sim.7033.
  • Altman, D. G. (1994), “The Scandal of Poor Medical Research,” BMJ, 308, 283–384. DOI: 10.1136/bmj.308.6924.283.
  • Altman, D. G., and Bland, J. M. (1983), “Measurement in Medicine: The Analysis of Method Comparison Studies,” The Statistician, 32, 307–317. DOI: 10.2307/2987937.
  • Amrhein, V., Greenland, S., and McShane, B. (2019), “Scientists Rise up against Statistical Significance.” Nature, 567, 305–307. DOI: 10.1038/d41586-019-00857-9.
  • Arnold, B., Bowler, L., Gibson, S., Herterich, P., Higman, R., Krystalli, A., Morley, A., O’Reilly, M., and Whitaker, K. (2019), The Turing Way: A Handbook for Reproducible Data Science (Version v0.0.4). Zenodo, March 25. DOI: 10.5281/zenodo.3233986.
  • Arnold, K. F., Davies, V., de Kamps, M., Tennant, P. W. G., Mbotwa, J., and Gilthorpe, M. S. (2020), “Reflections on Modern Methods: Generalized Linear Models for Prognosis and Intervention-Theory, Practice and Implications for Machine Learning,” International Journal of Epidemiology, 49, 2074–2082. DOI: 10.1093/ije/dyaa049.
  • Baker, M. (2016), “1,500 Scientists Lift the Lid on Reproducibility,” Nature, 533, 452–454. DOI: 10.1038/533452a.
  • Blei, D. M., and Smyth, P. (2017), “Science and Data Science,” Proceedings of the National Academy of Sciences of the United States of America, 114, 8689–8692. DOI: 10.1073/pnas.1702076114.
  • Boulesteix, A.-L., Groenwold, R. H., Abrahamowicz, M., Binder, H., Briel, M., Hornung, R., Morris, T. P., Rahnenführer, J., and Sauerbrei, W. (2020), “Introduction to Statistical Simulations in Health Research,” BMJ Open, 10, e039921. DOI: 10.1136/bmjopen-2020-039921.
  • Bourne, P. E. (2021), “Is ‘Bioinformatics’ Dead?,” PloS Biology, 19, e3001165. DOI: 10.1371/journal.pbio.3001165.
  • Cao, L. (2018), “Data Science Thinking,” in Data Science Thinking: The Next Scientific, Technological and Economic Revolution, ed. L. Cao, pp. 59–90, Cham: Springer.
  • Caruana, R., Lou, Y., Gehrke, J., Koch, P., Sturm, M., and Elhadad, N. (2015), “Intelligible Models for HealthCare: Predicting Pneumonia Risk and Hospital 30-Day Readmission,” in Proceedings of the 21th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 1721–30. KDD ’15, New York: Association for Computing Machinery. DOI: 10.1145/2783258.2788613.
  • Chambers, J. M. (1993), “Greater or Lesser Statistics: A Choice for Future Research,” Statistics and Computing, 3, 182–184. DOI: 10.1007/BF00141776.
  • Chatfield, C. (1991), “Avoiding Statistical Pitfalls,” Schweizerische Monatsschrift Fur Zahnheilkunde = Revue Mensuelle Suisse D’odonto-Stomatologie/SSO, 6, 240–252.
  • Chatfield, C. (2002), “Confessions of a Pragmatic Statistician,” Journal of the Royal Statistical Society, Series D, 51, 1–20. DOI: 10.1111/1467-9884.00294.
  • Cleveland, W. S. (2001), “Data Science: An Action Plan for Expanding the Technical Areas of the Field of Statistics,” International Statistical Review = Revue Internationale de Statistique, 69, 21–26.
  • Cox, D. R. (2017), “Statistical Science: A Grammar for Research,” European Journal of Epidemiology, 32, 465–471. DOI: 10.1007/s10654-017-0288-1.
  • Debray, T. P. A., Damen, J. A. A. G., Snell, K. I. E., Ensor, J., Hooft, L., Reitsma, J. B., Riley, R. D., and Moons, K. G. M. (2017), “A Guide to Systematic Review and Meta-Analysis of Prediction Model Performance,” BMJ (Clinical Research ed.), 356, i6460.
  • Devezer, B., Navarro, D. J., Vandekerckhove, J., and Ozge Buzbas, E. (2021), “The Case for Formal Methodology in Scientific Reform,” Royal Society Open Science, 8, 200805. DOI: 10.1098/rsos.200805.
  • Diggle, P. J. (2015), “Statistics: A Data Science for the 21st Century,” Journal of the Royal Statistical Society, Series A 178, 793–813. DOI: 10.1111/rssa.12132.
  • “Do No Harm: An Ethical Data Life Cycle.” n.d. Accessed April 14, 2021, available at https://www.aaaspolicyfellowships.org/blog/do-no-harm-ethical-data-life-cycle.
  • Donoho, D. (2017), “50 Years of Data Science,” Journal of Computational and Graphical Statistics, 26, 745–766. DOI: 10.1080/10618600.2017.1384734.
  • “E9 (R1) Step 5 Addendum on Estimands and Sensitivity Analysis in Clinical Trials to the Guideline on Statistical Principles for Clinical Trials,” n.d. Available at https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical-principles_en.pdf.
  • Efron, B., and Hastie, T. (2016), Computer Age Statistical Inference, Cambridge: Cambridge University Press.
  • EMBL. n.d. “[No Title].” Accessed June 2, 2021. Available at https://www.embl.org/.
  • Ferrero, E., Brachat, S., Jenkins, J. L., Marc, P., Skewes-Cox, P., Altshuler, R. C., Gubser Keller, C., Kauffmann, A., Sassaman, E. K., Laramie, J. M., Schoeberl, B., Borowsky, M. L., and Stiefl, N. (2020), “Ten Simple Rules to Power Drug Discovery with Data Science,” PloS Computational Biology, 16, e1008126. DOI: 10.1371/journal.pcbi.1008126.
  • Fineberg, H., Stodden, V., and Meng, X.-L. (2020), “Highlights of the US National Academies Report on ‘Reproducibility and Replicability in Science”’ Harvard Data Science Review, 2, 1–11. DOI: 10.1162/99608f92.cb310198.
  • Fleming, T. R., DeMets, D. L., Roe, M. T., Wittes, J., Calis, K. A., Vora, A. N., Meisel, A., Bain, R. P., Konstam, M. A., Pencina, M. J., Gordon, D. J., Mahaffey, K. W., Hennekens, C. H., Neaton, J. D., Pearson, G. D., Andersson, T. L., Pfeffer, M. A., and Ellenberg, S. S. (2017), “Data Monitoring Committees: Promoting Best Practices to Address Emerging Challenges,” Clinical Trials (London, England), 14, 115–123. DOI: 10.1177/1740774516688915.
  • Gawande, A. (2009), The Checklist Manifesto: How to Get Things Right, New York: Metropolitan Books.
  • Gelman, A., and Loken, E. (2014), “The Statistical Crisis in Science: Data-Dependent Analysis–a ‘Garden of Forking Paths’–Explains Why Many Statistically Significant Comparisons Don’t Hold Up,” American Scientist, 102, 460–466.
  • Gelman, A., and Vehtari, A. (2020), “What Are the Most Important Statistical Ideas of the Past 50 Years?” arXiv [stat.ME]. arXiv. http://arxiv.org/abs/2012.00174.
  • Gelman, A., Vehtari, A., Simpson, D., Margossian, C. C., Carpenter, B., Yao, Y., Kennedy, L., Gabry, J., Bürkner, P.-C., and Modrák, M. (2020) “Bayesian Workflow.” arXiv [stat.ME]. arXiv. http://arxiv.org/abs/2011.01808.
  • Gibson, E. W. (2019), “Leadership in Statistics: Increasing Our Value and Visibility,” The American Statistician, 73, 109–116. DOI: 10.1080/00031305.2017.1336484.
  • Glass, D. J. (2010), “A Critique of the Hypothesis, and a Defense of the Question, as a Framework for Experimentation,” Clinical Chemistry, 56, 1080–1085. DOI: 10.1373/clinchem.2010.144477.
  • Greenhouse, J. B., and Seltman, H. J. (2018), “On Teaching Statistical Practice: From Novice to Expert,” The American Statistician, 72, 147–154. DOI: 10.1080/00031305.2016.1270230.
  • Hand, D. J. (1994), “Deconstructing Statistical Questions,” Journal of the Royal Statistical Society, Series A, 157, 317–356. DOI: 10.2307/2983526.
  • Hand, D. J. (2006), “Classifier Technology and the Illusion of Progress,” Statistical Science: A Review Journal of the Institute of Mathematical Statistics, 21, 1–14.
  • Hernán, M. A., and Robins, J. M. (2016), “Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available,” American Journal of Epidemiology, 183, 758–764. DOI: 10.1093/aje/kwv254.
  • Hernan, M. A., and Robins, J. M. (2019), Causal Inference, Boca. Raton, FL: Taylor & Francis.
  • Hernán, M. A., Hsu, J., and Healy, B. (2019), “A Second Chance to Get Causal Inference Right: A Classification of Data Science Tasks,” Chance, 32, 42–49. DOI: 10.1080/09332480.2019.1579578.
  • Huebner, M., Vach, W., and Le Cessie, S. (2016), “A Systematic Approach to Initial Data Analysis Is Good Research Practice,” The Journal of Thoracic and Cardiovascular Surgery, 151, 25–27. DOI: 10.1016/j.jtcvs.2015.09.085.
  • “ICH Official Web Site: ICH.” n.d. Accessed June 3, 2021. Available at https://www.ich.org/.
  • International Conference on Harmonisation (ICH). (2018a), “ICH E8 General Considerations for Clinical Studies,” September 17, 2018. https://www.ema.europa.eu/en/ich-e8-general-considerations-clinical-studies.
  • International Conference on Harmonisation (ICH). “ICH E9 Statistical Principles for Clinical Trials.” September 17, 2018, available at https://www.ema.europa.eu/en/ich-e9-statistical-principles-clinical-trials.
  • Keller, S. A., Shipp, S. S., Schroeder, A. D., and Korkmaz, G. (2020), “Doing Data Science: A Framework and Case Study,” 2.1.
  • Kenett, R. S., and Shmueli, G. (2015), “Clarifying the Terminology That Describes Scientific Reproducibility,” Nature Methods, 12, 699. DOI: 10.1038/nmeth.3489.
  • Krieger, N., and Davey Smith, G. (2016), “The Tale Wagged by the DAG: Broadening the Scope of Causal Inference and Explanation for Epidemiology,” International Journal of Epidemiology, 45, 1787–1808. DOI: 10.1093/ije/dyw114.
  • Kuemmel, C., Yang, Y., Zhang, X., Florian, J., Zhu, H., Tegenge, M., Huang, S-M., Wang, Y., Morrison, T., and Zineh, I. (2020), “Consideration of a Credibility Assessment Framework in Model-Informed Drug Development: Potential Application to Physiologically-Based Pharmacokinetic Modeling and Simulation,” CPT: Pharmacometrics & Systems Pharmacology, 9, 21–28.
  • Leek, J. T., and Peng, R. D. (2015), “Statistics: P Values Are Just the Tip of the Iceberg,” Nature 520, 612. DOI: 10.1038/520612a.
  • Liu, G., Lu, D., and Lu, J. (2021), “Pharm-AutoML: An Open-Source, End-to-End Automated Machine Learning Package for Clinical Outcome Prediction,” CPT: Pharmacometrics & Systems Pharmacology, 10, 478–488.
  • Mallows, C. (1998), “The Zeroth Problem,” The American Statistician, 52, 1–9.
  • McElreath, R. (2020), Statistical Rethinking: A Bayesian Course with Examples in R and Stan, Boca Raton, FL: CRC Press.
  • Meyer, E. L., Mesenbrink, P., Dunger-Baldauf, C., Fülle, H.-J., Glimm, E., Li, Y., Posch, M., and König, F. (2020), “The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review,” Clinical Therapeutics, 42, 1330–1360. DOI: 10.1016/j.clinthera.2020.05.010.
  • Morris, T. P., White, I. R., and Crowther, M. J. (2019), “Using Simulation Studies to Evaluate Statistical Methods,” Statistics in Medicine, 38, 2074–2102. DOI: 10.1002/sim.8086.
  • Mukherjee, S., and Richardson, S. (2020), “The Future of Data Science,” Harvard Data Science Review, 2, 1–18.
  • Munafò, M. R., Nosek, B. A., Bishop, D. V. M., Button, K. S., Chambers, C. D., Du Sert, N. P., Simonsohn, U., Wagenmakers, E.-J., Ware, J. J., and Ioannidis, J. P. A. (2017), “A Manifesto for Reproducible Science,” Nature Human Behaviour, 1, 0021. DOI: 10.1038/s41562-016-0021.
  • Neff, G., Tanweer, A., Fiore-Gartland, B., and Osburn, L. (2017), “Critique and Contribute: A Practice-Based Framework for Improving Critical Data Studies and Data Science,” Big Data, 5, 85–97. DOI: 10.1089/big.2016.0050.
  • Nelder, J. A. (1986), “Statistics, Science and Technology,” Journal of the Royal Statistical Society, Series A, 149, 109–121. DOI: 10.2307/2981525.
  • Nosek, B. n.d. “Strategy for Culture Change.” Accessed April 6, 2021, available at https://www.cos.io/blog/strategy-for-culture-change.
  • “OHDSI – Observational Health Data Sciences and Informatics.” n.d. Accessed June 2, 2021. https://ohdsi.org/.
  • “Open Science – OECD.” n.d. Accessed June 2, 2021, available at https://www.oecd.org/sti/inno/open-science.htm.
  • Pajouheshnia, R., Groenwold, R. H. H., Peelen, L. M., Reitsma, J. B., and Moons, K. G. M. (2019), “When and How to Use Data from Randomised Trials to Develop or Validate Prognostic Models,” BMJ (Clinical Research ed.), 365, l2154.
  • Parker, H. (2017), “Opinionated Analysis Development.” e3210v1. PeerJ Preprints. Available at DOI: 10.7287/peerj.preprints.3210v1.
  • Picard, R. R., and Cook, R. D. (1984), “Cross-Validation of Regression Models,” Journal of the American Statistical Association 79, 575–583. DOI: 10.1080/01621459.1984.10478083.
  • “PRISMA.” n.d. Accessed December 21, 2020, available at http://www.prisma-statement.org/.
  • Rajkomar, A., Oren, E., Chen, K., Dai, A. M., Hajaj, N., Hardt, M., Liu, P. J., Liu, X., Marcus, J., Sun, M., Sundberg, P., Yee, H., Zhang, K., Zhang, Y., Flores, G., Duggan, G. E., Irvine, J., Le, Q., Litsch, K., Mossin, A., Tansuwan, J., Wang, D., Wexler, J., Wilson, J., Ludwig, D., Volchenboum, S. L., Chou, K., Pearson, M., Madabushi, S., Shah, N. H., Butte, A. J., Howell, M. D., Cui, C., Corrado, G. S., and Dean, J. (2018), “Scalable and Accurate Deep Learning with Electronic Health Records,” NPJ Digital Medicine, 1, 18. DOI: 10.1038/s41746-018-0029-1.
  • “Rss-Report-Opps-and-Ethics-of-Big-Data-Feb-2016.pdf.” n.d.
  • Rubinstein, A., and Chor, B. (2014), “Computational Thinking in Life Science Education,” PloS Computational Biology, 10, e1003897. DOI: 10.1371/journal.pcbi.1003897.
  • Rudin, C., J. and Radin, (2019), “Why Are We Using Black Box Models in AI When We Don’t Need to? A Lesson from an Explainable AI Competition.” 1.2 1 (2).
  • Saltelli, A. (2020), “Ethics of Quantification or Quantification of Ethics?” Futures, 116, 102509. DOI: 10.1016/j.futures.2019.102509.
  • Schuemie, M. J., Ryan, P. B., Pratt, N., Chen, R., You, S. C., Krumholz, H. M., Madigan, D., Hripcsak, G., and Suchard, M. A. (2020), “Principles of Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND),” Journal of the American Medical Informatics Association: JAMIA, 27, 1331–1337. DOI: 10.1093/jamia/ocaa103.
  • Senge, P. M. (2006), The Fifth Discipline: The Art and Practice of the Learning Organization, New York: Currency.
  • Sheiner, L. B. (1997), “Learning versus Confirming in Clinical Drug Development.” Clinical Pharmacology and Therapeutics, 61, 275291. DOI: 10.1016/S0009-9236(97)90160-0.
  • Shmueli, G. (2010), “To Explain or to Predict?” Statistical Science, 25, 289–310. DOI: 10.1214/10-STS330.
  • Stan Development Team. n.d. “Stan User’s Guide.” Accessed June 2, 2021. Available at https://mc-stan.org/docs/2_26/stan-users-guide/index.html.
  • Stark, P. B. (2018), “Before Reproducibility Must Come Preproducibility,” Nature, 557, 613. DOI: 10.1038/d41586-018-05256-0.
  • Stark, P. B., and Saltelli, A. (2018), “Cargo-Cult Statistics and Scientific Crisis,” Significance (Oxford, England), 15, 40–43. DOI: 10.1111/j.1740-9713.2018.01174.x.
  • Steuer, D. (2020), “Time for Data Science to Professionalise,” Significance (Oxford, England), 17, 44–45. DOI: 10.1111/1740-9713.01430.
  • Stodden, V. (2020), “The Data Science Life Cycle: A Disciplined Approach to Advancing Data Science as a Science,” Communications of the ACM, 63, 58–66. DOI: 10.1145/3360646.
  • Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., Liu, B., Matthews, P., Ong, G., Pell, J., Silman, A., Young, A., Sprosen, T., Peakman, T., and Collins, R. (2015), “UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age,” PloS Medicine, 12, e1001779. DOI: 10.1371/journal.pmed.1001779.
  • Tansley, S., and Tolle, K. M. (2009), Jim Gray on eScience: A Transformed Scientific Method, available at http://www.academia.edu/download/53717445/Fourth_Paradigm.pdf#page=19.
  • “The EQUATOR Network.” n.d. Accessed December 21, 2020, available at https://www.equator-network.org/.
  • The Royal Statistical Society (RSS) and the Institute and Faculty of Actuaries (IFoA). (2019), “A Guide for Ethical Data Science: A Collaboration between the Royal Statistical Society (RSS) and the Institute and Faculty of Actuaries (IFoA),” available at https://rss.org.uk/RSS/media/News-and-publications/Publications/Reports%20and%20guides/A-Guide-for-Ethical-Data-Science-Final-Oct-2019.pdf.
  • Tong, C. (2019), “Statistical Inference Enables Bad Science; Statistical Thinking Enables Good Science,” The American Statistician, 73, 246–261. DOI: 10.1080/00031305.2018.1518264.
  • Tractenberg, R. E. (2020a), “Concordance of Professional Ethical Practice Standards for the Domain of Data Science: A White Paper.” DOI: 10.31235/osf.io/p7rj2.
  • Tractenberg, R. E. (2020b), “Ten Simple Rules for Integrating Ethics into Statistics and Data Science Instruction.” DOI: 10.31235/osf.io/z9uej.
  • Tukey, J. W. (1962), “The Future of Data Analysis,” The Annals of Mathematical Statistics, 33, 1–67. DOI: 10.1214/aoms/1177704711.
  • Tukey, J. W. (1977), Exploratory Data Analysis. (Vol. 2). Reading, MA.
  • Tukey, J. W. (1986), “Sunset Salvo,” The American Statistician, 40, 72–76.
  • Turner, R. M., Spiegelhalter, D. J., Smith, G. C. S., and Thompson, S. G. (2009), “Bias Modelling in Evidence Synthesis,” Journal of the Royal Statistical Society: Series A (Statistics in Society), 172, 21–47. DOI: 10.1111/j.1467-985X.2008.00547.x.
  • “UK Biobank – UK Biobank.” n.d. Accessed June 2 2021, available at https://www.ukbiobank.ac.uk/.
  • Van Calster, B., Wynants, L., Timmerman, D., Steyerberg, E. W., and Collins, G. S. (2019), “Predictive Analytics in Health Care: How Can We Know It Works?” Journal of the American Medical Informatics Association: JAMIA, 26, 1651–1654. DOI: 10.1093/jamia/ocz130.
  • Vickers, A. (2005), “Interpreting Data from Randomized Trials: The Scandinavian Prostatectomy Study Illustrates Two Common Errors,” Nature Clinical Practice. Urology, 2, 404–405. DOI: 10.1038/ncpuro0294.
  • Weber, L. M., Saelens, W., Cannoodt, R., Soneson, C., Hapfelmeier, A., Gardner, P. P., Boulesteix, A.-L., Saeys, Y., and Robinson, M. D. (2019), “Essential Guidelines for Computational Method Benchmarking,” Genome Biology, 20, 125. DOI: 10.1186/s13059-019-1738-8.
  • Weihs, C., and Ickstadt, K. (2018), “Data Science: The Impact of Statistics,” International Journal of Data Science and Analytics, 6, 189–194. DOI: 10.1007/s41060-018-0102-5.
  • Welton, N. J., Sutton, A. J., Cooper, N., Abrams, K. R., and Ades, A. E. (2012), Evidence Synthesis for Decision Making in Healthcare (Vol. 132), Chichester: Wiley.
  • Wickham, H. (2014), “Tidy Data,” Journal of Statistical Software, 59, 1–23. DOI: 10.18637/jss.v059.i10.
  • Wild, C. J., and Pfannkuch, M. (1999), “Statistical Thinking in Empirical Enquiry,” International Statistical Review = Revue Internationale de Statistique, 67, 223–248.
  • Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., Bouwman, J., Brookes, A. J., Clark, T., Crosas, M., Dillo, I., Dumon, O., Edmunds, S., Evelo, C. T., Finkers, R., Gonzalez-Beltran, A., Gray, A. J. G., Groth, P., Goble, C., Grethe, J. S., Heringa, J., ’t Hoen, P. A. C., Hooft, R., Kuhn, T., Kok, R., Kok, J., Lusher, S. J., Martone, M. E., Mons, A., Packer, A. L., Persson, B., Rocca-Serra, P., Roos, M., van Schaik, R., Sansone, S.-A., Schultes, E., Sengstag, T., Slater, T., Strawn, G., Swertz, M. A., Thompson, M., van der Lei, J., van Mulligen, E., Velterop, J., Waagmeester, A., Wittenburg, P., Wolstencroft, K., Zhao, J., and Mons, B. (2016), “The FAIR Guiding Principles for Scientific Data Management and Stewardship,” Scientific Data, 3, 160018. DOI: 10.1038/sdata.2016.18.
  • Willis, C., and Stodden, V. (2020), “Trust but Verify: How to Leverage Policies, Workflows, and Infrastructure to Ensure Computational Reproducibility in Publication,” Harvard Data Science Review, 2, 1–60. DOI: 10.1162/99608f92.25982dcf.
  • Wilson, G., Bryan, J., Cranston, K., Kitzes, J., Nederbragt, L., and Teal, T. K. (2017), “Good Enough Practices in Scientific Computing,” PloS Computational Biology, 13, e1005510. DOI: 10.1371/journal.pcbi.1005510.
  • Wing, J. M. (2006), “Computational Thinking,” Communications of the ACM, 49, 33–35. DOI: 10.1145/1118178.1118215.
  • Wing, J. M. (2019), “The Data Life Cycle.” Issue 1, June. DOI: 10.1162/99608f92.e26845b4.
  • Wing, J. M., D. and Banks, (2019), “Highlights of the Inaugural Data Science Leadership Summit.” 1.2, November, available at DOI: 10.1162/99608f92.e45fcb79.
  • Winkler, J. K., Fink, C., Toberer, F., Enk, A., Deinlein, T., Hofmann-Wellenhof, R., Thomas, L., Lallas, A., Blum, A., Stolz, W., and Haenssle, H. A. (2019), “Association Between Surgical Skin Markings in Dermoscopic Images and Diagnostic Performance of a Deep Learning Convolutional Neural Network for Melanoma Recognition,” JAMA Dermatology, 155, 1135–1141. DOI: 10.1001/jamadermatol.2019.1735.
  • Zame, W. R., Bica, I., Shen, C., Curth, A., Lee, H.-S., Bailey, S., Weatherall, J., Wright, D., Bretz, F., and van der Schaar, M. (2020), “Machine Learning for Clinical Trials in the Era of COVID-19,” Statistics in Biopharmaceutical Research, 12, 506–517. DOI: 10.1080/19466315.2020.1797867.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.